Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › CA › SAN DIEGO › SEQUENOM CENTER FOR MOLECULAR MEDICINE LLC

SEQUENOM CENTER FOR MOLECULAR MEDICINE LLC

NPI: 1730481078 · SAN DIEGO, CA 92121 · Clinical Medical Laboratory · NPI assigned 11/18/2010

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more

$74.16M
Total Medicaid Paid
238,481
Total Claims
217,174
Beneficiaries
19
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialWILLIAMS, KIMBERLY (VICE PRESIDENT)
Parent OrganizationSEQUENOM INC
NPI Enumeration Date11/18/2010

Related Entities

Other providers sharing the same authorized official: WILLIAMS, KIMBERLY

ProviderCityStateTotal Paid
LABORATORY CORPORATION OF AMERICA HOLDINGS BURLINGTON NC $1.44B
LABORATORY CORPORATION OF AMERICA HOLDINGS RARITAN NJ $717.47M
LABORATORY CORPORATION OF AMERICA HOLDINGS DUBLIN OH $617.02M
LABORATORY CORPORATION OF AMERICA HOLDINGS BIRMINGHAM AL $289.12M
LABORATORY CORPORATION OF AMERICA PHOENIX AZ $265.90M
LABORATORY CORPORATION OF AMERICA HOLDINGS BURLINGTON NC $264.26M
LABORATORY CORPORATION OF AMERICA HOLDINGS CHARLESTON WV $220.04M
LABORATORY CORPORATION OF AMERICA SEATTLE WA $186.69M
LABORATORY CORPORATION OF AMERICA TAMPA FL $171.13M
LABORATORY CORPORATION OF AMERICA SAN DIEGO CA $147.14M
LABORATORY CORPORATION OF AMERICA HOUSTON TX $103.81M
LABORATORY CORPORATION OF AMERICA ENGLEWOOD CO $77.80M
LABORATORY CORPORATION OF AMERICA DALLAS TX $77.42M
LABORATORY CORPORATION OF AMERICA BURLINGTON NC $59.75M
MEDTOX LABORATORIES, INC SAINT PAUL MN $47.72M
LABORATORY CORPORATION OF AMERICA HOLDINGS BURLINGTON NC $15.65M
LABORATORY CORPORATION OF AMERICA SAN ANTONIO TX $11.67M
TRI-CITIES LABORATORY, LLC KENNEWICK WA $8.69M
LABORATORY CORPORATION OF AMERICA HOLDINGS MONROE LA $3.39M
LABORATORY CORPORATION OF AMERICA ITASCA IL $3.37M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 22,400 $6.52M
2019 19,206 $5.45M
2020 22,525 $4.87M
2021 30,403 $7.52M
2022 32,015 $9.19M
2023 52,038 $18.44M
2024 59,894 $22.17M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel 207,643 189,557 $72.15M
81479 Unlisted molecular pathology procedure 10,451 8,938 $1.18M
81422 7,097 6,325 $395K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 1,661 1,549 $311K
81329 1,686 1,574 $31K
81361 430 409 $15K
81257 430 409 $13K
81243 1,303 1,231 $10K
81255 440 415 $8K
81251 440 415 $7K
81200 442 417 $7K
81260 440 415 $7K
81330 440 415 $7K
81242 440 415 $7K
81290 440 415 $7K
81209 440 415 $7K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 3,326 2,999 $4K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 883 813 $0.00
0009M 49 48 $0.00